IP Library Granted Patent US 7,235,107
Granted Patent B2
US 7,235,107 · App. 10/713,438 · Granted Jun 26, 2007

Devices and methods for treating defects in the tissue of a living being

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,107
App. No.
10/713,438
Granted
Jun 26, 2007
Kind
B2
Abstract

An implantable material for deployment in select locations or select tissue for tissue regeneration is disclosed. The implant comprises collagen, ceramics, and or other bio-resorbable materials or additives, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.

Claims (35)

1. A conformable, multi-phasic bone implant for the repair and regeneration of bone tissue, said implant consisting of a plastically deformable, tissue conductive matrix for tissue regeneration, said matrix consisting of two phases, wherein a first phase of said matrix consists of native insoluble collagen fibers and a second phase consists of soluble collagen, said implant having a consistency of a putty just prior to implantation, and remaining at least somewhat compliant after implantation.

2. A conformable, multi-phasic bone implant for the repair and regeneration of bone tissue, said implant comprising components that resorb in stages wherein:

a. At least a first of said components is a non-soluble ceramic granule;

b. At least a second of said components is native insoluble collagen fibers and

c. At least a third component is a flowable collagen gel;

wherein the ceramic granules are blended into the native insoluble collagen fibers as an admixture, and wherein the collagen gel holds the admixture of ceramic granules and native insoluble collagen fibers together, providing a level of structural integrity to the implant, and further wherein said porous implant is arranged for placement within a body of a living being, and still further wherein said implant is plastically deformable, tissue conductive, has a consistency of a putty just prior to implantation and retains at least some compliance following implantation.

3. The implant of claim 2 , wherein said native insoluble collagen fibers do not consist of collagen fibrils at the highest level of structural organization.

4. A conformable, multi-phasic bone implant for the repair and regeneration of a defect in a bone of a living being, said implant comprising a plurality of components that resorb in stages wherein:

a. At least a first component of said components is native insoluble collagen fibers; and

b. At least a second component of said components is a flowable soluble collagen gel;

wherein said porous implant is arranged for placement in a body of said living being, further wherein the implant is plastically deformable, tissue conductive, has a consistency of a putty just prior to implantation and retains at least some compliance following implantation, and further wherein the flowable soluble collagen gel is mixed with the native insoluble collagen fibers and holds the native insoluble collagen fibers together, providing a level of structural integrity to the implant.

5. The bone implant of claim 4 , wherein the implant initially comprises non-soluble collagen which is in the form of a depot surrounded by lyophilized soluble collagen prior to implantation, wherein the lyophilized soluble collagen collapses into said flowable gel upon hydration.

6. The bone implant of claim 5 , wherein said hydration occurs prior to implantation.

7. The bone implant of claim 4 , wherein said native insoluble collagen fibers do not consist of the fibrillar form of collagen at the highest level of structural organization.

8. A conformable, multi-phasic bone implant for the repair and regeneration of a defect in a bone of a living being, said implant comprising a plastically deformable, tissue conductive matrix for tissue regeneration, said matrix comprising at least two phases, wherein at least a first phase of said matrix comprises native insoluble collagen fibers and at least a second phase comprises a flowable biocompatible polymer comprising soluble collagen, further wherein said porous implant is suitable for placement within a body of said living being, said implant having a consistency of a putty just prior to implantation, and remaining at least somewhat compliant after implantation.

9. The implant of claim 8 , wherein the second phase is initially dry, and non-flowable, and said dry second phase becomes flowable following hydration.

10. The implant of claim 8 , wherein the second phase degrades faster than the first phase.

11. The implant of claim 10 , wherein the second phase acts as a delayed porosifying agent.

12. The implant of claim 8 , wherein the implant additionally comprises non-soluble chips or granules blended within said first phase as an admixture.

13. The implant of claim 12 , wherein the granules or chips are in the form of spheres.

14. The implant of claim 13 , wherein the granules or chips are in the form of micro spheres.

15. The implant of claim 12 , wherein the granules or chips are composed of ceramic.

16. The implant of claim 15 , wherein the ceramic is a tricalcium phosphate.

17. The implant of claim 16 , wherein the tricalcium phosphate is porous.

18. The implant of claim 12 , wherein the granules or chips comprise bone.

19. The implant of claim 18 , wherein the bone has been demineralized.

20. The implant of claim 12 , wherein the granules or chips improve the mechanical, biological or resorption characteristics of said implant.

21. The implant of claim 8 , wherein the matrix further comprises biologically active or pharmaceutical agent.

22. The implant of claim 21 , wherein the agent is added to the implant at, or immediately prior to placement of said implant into said tissue.

23. The implant of claim 22 , wherein the agent comprises at least one of a biologically active agent, a pharmaceutical, and an active agent.

24. The implant of claim 23 , wherein the biologically active agent comprises cells.

25. The implant of claim 24 , wherein the cells are supplied as a constituent of blood or bone marrow.

26. In combination with the implant of claim 8 , a syringe, wherein the conformable, multi-phasic implant is arranged to be stored and delivered with said syringe.

27. In combination with the implant of claim 8 , a syringe-like cylindrical housing, wherein the conformable, multi-phasic implant is arranged to be stored and delivered with said syringe-like cylindrical housing.

28. In combination with the implant of claim 27 , a laproscopic cannula or incision comprising a channel, wherein the cylindrical housing comprises a cross-sectional configuration which is arranged to permit sliding passage through the channel.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2017
From: KENSEY NASH BVF
To: DSM IP ASSETS B.V.
Reel/Frame 043343/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: KENSEY NASH HOLDING CORPORATION
To: KENSEY NASH BVF TECHNOLOGY, LLC
Reel/Frame 024906/0466 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2010
From: KENSEY NASH CORPORATION
To: KENSEY NASH HOLDING CORPORATION
Reel/Frame 024906/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2004
From: EVANS, DOUGLAS G.; GOLDMAN, SCOTT M.; KRONENGOLD, RUSSEL T.
To: KENSEY NASH CORPORATION
Reel/Frame 014358/0042 →